ASHLEY ELIZABETH BELLOW

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAKE CHARLES, LA NPI 1124583828

General Payments — all program years on this page

$703.93

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $357.35 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $357.3519

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $80.384
Paratek Pharmaceuticals, Inc. $74.754
ABBVIE INC. $66.993
Astellas Pharma US Inc $50.673
PFIZER INC. $38.272
Amgen Inc. $31.022
IDORSIA PHARMACEUTICALS US INC $15.271

By program year

Program yearAmountRecords
2021 $55.584
2022 $162.9713
2023 $128.038
2024 $357.3519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105310082 AstraZeneca Pharmaceuticals LP $17.84 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105441388 AstraZeneca Pharmaceuticals LP $19.85 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105524779 AstraZeneca Pharmaceuticals LP $24.07 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105602842 AstraZeneca Pharmaceuticals LP $18.62 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106510086 ABBVIE INC. $20.48 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106510088 ABBVIE INC. $27.32 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106510090 ABBVIE INC. $19.19 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113925302 Paratek Pharmaceuticals, Inc. $17.72 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113925304 Paratek Pharmaceuticals, Inc. $19.43 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113925306 Paratek Pharmaceuticals, Inc. $17.22 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113925308 Paratek Pharmaceuticals, Inc. $20.38 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115445752 Amgen Inc. $15.42 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117504842 Amgen Inc. $15.60 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131196537 PFIZER INC. $18.29 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131870754 PFIZER INC. $19.98 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139499750 Astellas Pharma US Inc $17.86 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139511993 Astellas Pharma US Inc $19.10 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139542712 Astellas Pharma US Inc $13.71 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146774978 IDORSIA PHARMACEUTICALS US INC $15.27 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.